Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Name: Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
Published: 2013
License: Public Domain

Gilead Sciences · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

anti-infective-agents antiviral-agents hepatitis hepatitis-c-virus liver-diseases viral

hepatitis c virus, liver diseases, digestive system diseases, hepatitis, viral, human, virus diseases, enterovirus infections, picornaviridae infections, rna virus infections, flaviviridae infections, antiviral agents, anti-infective agents, therapeutic uses

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 838401
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.